Hi there,

The job of a journalist is to go to where the silence is — especially when those in power seek to silence voices that question or challenge power. That is what we do at Democracy Now! day in and day out, and we're able to do it because of financial support from people like you — people who trust and depend on our independent reporting. If you believe that freedom of speech and freedom of the press are essential to the functioning of a democratic society, please donate today. Every dollar makes a difference. Thank you so much.

Democracy Now!
Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Florida Executes Prisoner Using Anesthetic Untested in Executions

HeadlineAug 25, 2017

In Florida, prison officials on Thursday injected a 53-year-old condemned prisoner with a dose of an anesthetic never before used in a U.S. execution. At 6:10 p.m., Mark James Asay was strapped to a gurney and administered the drug etomidate. Witnesses say Asay twitched his legs briefly and appeared to breathe rapidly before his death was declared at 6:22 p.m. Etomidate was developed by Janssen, a division of Johnson & Johnson, and has been criticized as being unproven in executions. In response, the company said, “We do not condone the use of our medicines in lethal injections for capital punishment.” Mark James Asay was the first white man to be put to death in Florida for killing a black man since the state reinstituted the death penalty in 1979. We’ll have more on the death penalty and last night’s execution in Florida later in the broadcast.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top